Calciotropic hormones and nephrolithiasis

Mineral and Electrolyte Metabolism

Volumn 23, Issue 3-6, 1997, Pages 269-272

  D'Angelo, Angela ^a   Calo L ^b   Cantaro, S ^b   Giannini, S ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

Calcitonin; Calcium; Hypercalciuria; Hyperoxaluria; Nephrolithiasis; Parathyroid hormone; Vitamin D

Indexed keywords

CALCITRIOL; PARATHYROID HORMONE; THIAZIDE DIURETIC AGENT;

BONE DEMINERALIZATION; CALCIUM BALANCE; CONFERENCE PAPER; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; HYPERPARATHYROIDISM; NEPHROLITHIASIS; PRIORITY JOURNAL;

CALCITONIN; CALCITRIOL; HUMANS; KIDNEY CALCULI; PARATHYROID HORMONE;

EID: 0030680123     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Giannini S, Nobile M, Castrignano R, Pati T, Tasca A, Villi G, Pellegrini F, D'Angelo A: Possible link between vitamin D and hyperoxaluria in patients with renal stone disease. Clin Sci 1993;84:51-54.
2. Pak CYC, Britton F, Peterson R, Ward D, Northcutt C, Breslan NA, McGuire J, Sakhall K, Bush S, Nicar M, Norman DA, Peter P: Ambulatory evaluation of nephrolithiasis: Classification, clinical presentation and diagnostic criteria. Am J Med 1980;69:19-30.
3. D'Angelo A, Lodetti MG, Giannini S, Castrignano R, Al Awady M, Malvasi L, Fabris A, Maschio G: Hyperparathyroidism: Cause or consequence of recurrent calcium nephrolithiasis? Miner Electrolyte Metab 1992;18:359-364.
4. Hess B, Lippuner K, Takkinen R, Villiger L, Ackermann D, Jaeger P: Effect of oral calcium loading on intact PTH and calcitriol in idiopathic renal calcium stone formers and healthy controls. Nephrol Dial Transplant 1995;10:1614-1619.
5. Messa P, Mioni G, Franzon R, Messa M, Cruciatti A, Giannini S, D'Angelo A: Factors affecting fasting urine calcium excretion in stone former patients on different dietary calcium intake. Scan Microsc 1992;6:239-246.
6. Nobile M, Calò L, Giannini S, Cantaro S, Carraro G, Vianello D, Tasca A, D'Angelo A: Bone mineral density and metabolism in patients with idiopathic hypercalciuria and recurrent calcium nephrolithiasis; in Pak CYC, Resnick MI, Preminger GM (eds): Urolithiasis 96. Dallas, Millet, 1996, pp 488-489.
7. Alhava EM, Junti M, Karjalainen P: Bone mineral density in patients with urolithiasis. Scand J Urol Nephrol 1976;10:154-156.
8. Barkin J, Wilson DR, Manuel MA, Bayley A, Murray T, Harrison J: Bone mineral content in idiopathic calcium nephrolithiasis. Miner Electrolyte Metab 1985;11:19-24.
9. Malvasi L, Sartori L, Giannini S, Al Awady M, Musaio F, Varotto S, D'Angelo A: Mineral metabolism and bone mineral content in calcium nephrolithiasis with and without hyperparathyroidism (abstract). Urol Res 1988;16:190.
10. Borghi L, Meschi T, Guezzo A, Maninetti L, Pedrazzoni M, Marcato A, Vescovi P, Novarini A: Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol 1991;146:1334-1338.
11. Jaeger P: Relative hupoparathyroidism and calcitriol up-regulation in hypercalciuric calcium renal stone formers: Impact of nutrition. Am J Nephrol 1993;13:18-26.
12. Hess B, Ackermann D, Essig M, Takkinen R, Jaeger P: Renal mass and serum calcitriol in male idiopathic calcium renal stone formers: Role of protein intake. J Clin Endocrinol Metab 1995;80:1916-1921.
13. Pacifici R, Rothstein M, Rifas L, Lau KW, Baylenk DJ, Avioli LV, Hruska K: Increased monocyte interleukin 1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metabol 1990;71:138-145.
14. Pietschmann F, Breslan NA, Pak CYC: Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 1992;12:1383-1388.
15. Bataille P, Achard JM, Fournier A, Boudailliez B, Westeel PF, El Esper N, Bergot C, Jans I, Lacou JD, Petit J, Henon G, Laral Jeantet MA, Bouillon R, Schert JL: Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 1991;39:1193-1205.
16. Yendt ER, Cohanim M: Prevention of calcium stones with thiazides. Kidney Int 1978;13:397-409.
17. Transbol I, Christensen GF, Jensen GF, Christensen C, McNair P: Thiazide for the postponement of postmenopausal bone loss. Metabolism 1982;31:383-386.
18. Brickman AS, Massry SG, Coburn JW: Changes in serum and urinary calcium during treatment with hydrochlorothiazide: Studies on mechanisms. J Clin Invest 1972;51:945-954.
19. Zerwekh JE, Pak CYC: Selective effects of thiazide therapy on serum 1α, 25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciuria. Metabolism 1980;29:13-17.
20. Betend L, David M, Vincent M, Hermier M, Francois F: Successful indomethacin treatment of 2 pediatric patients with severe tubulopathies. Helv Pediatr Acta 1979;34:339-344.
21. Donker AJ, De Jong PE, Statius van Eps LW, Bretjens JR, Bakker K, Doorebos H: Indomethacin in Bartter's syndrome. Nephron 1977;19:200-213.
22. 2 synthesis? Clin Sci 1990;78:321-325.
23. Ortalda V, Fabris A, D'Angelo A, Giannini S, Perobelli L, Maschio G: Correlation between recurrence of nephrolithiasis and persistence of bone resorption in patients with recurrent calcium nephrolithiasis on long term thiazide therapy; in Walker VR, Sutton RAL, Bert Cameron EC, Pak CYC, Robertson WG (eds): Urolithiasis. Dallas, Millet, 1989, pp 793-795.
24. Calò L, Cantaro S, Piccoli A, D'Angelo A, Giannini S, Williams HE, Borsatti A: Effect of nifedipine on urinary excretion of calcium and calcium-controlling hormones in essential hypercalciuria. Cardiovasc Drugs Ther 1990;4:983-986.
25. Castrignano R, Pati T, Tronca R, Nobile M, Lodetti MG, Benetollo P, Al Awady M, D'Angelo A: Nephrolithiasis and calcium excretion (abstract). 11th Int Congr Nephrol, Tokyo 1990.
26. Silverberg ST, Shane E, Jacobi TP, Siris ES, Gartemberg F, Seldin D, Clemens TL, Bilezikian JP: Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 1990;89:327-334.
27. D'Angelo A, Fabris A, Panebianco R, Ortalda V, Sartori L, Giannini S, Maschio G, Crepaldi G: What happens to patients with primary hyperparathyroidism and calcium nephrolithiasis after successful parathyroidectomy? Miner Metab Res Italy 1984;5:23-26.
28. Arnold A, Staunton CE, Goo Kim H, Gaz RD, Kronenberg HM: Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 1988;318:658-662.
29. Palmieri GM: Calcium, why and how much? Miner Electrolyte Metab 1995;21:236-241.
30. Weisinger JR: New insights into the pathogenesis of idiopathic hypercalciuria: The role of bone. Kidney Int 1996;49:1507-1518.
31. Borsatti A: Calcium oxalate nephrolithiasis: Defective oxalate transport. Kidney Int 1991;39:1283-1298.
32. Marangella M, Fruttero B, Bruno M, Linari F: Hyperoxaluria in idiopathic calcium stone disease: Further evidence of calcium hyperabsorption of oxalate. Clin Sci 1982;63:381-385.